PHARMACHEM KEFVET 250 MG TABLETS for Dogs and Cats

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

CEPHALEXIN

Disponível em:

PHARMACHEM AUSTRALIA PTY LTD

Forma farmacêutica:

ORAL TABLET

Composição:

CEPHALEXIN ANTIBIOTIC Active 250.0 mg/Tb

Unidades em pacote:

10 tablets; 100 tablets; 100 tablets (10 x 10); 300 tablets ( 30 x 10)

Classe:

VM - Veterinary Medicine

Área terapêutica:

ANTIBIOTIC & RELATED

Resumo do produto:

Poison schedule: 4; Withholding period: N/A N/A; Host/pest details: CAT: [INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE SKIN, INFECTIONS OF THE UROGENITAL TRACT, LOCALISED INFECTIONS IN SOFT TISSUE]; DOG: [INFECTIONS OF THE GASTROINTESTINAL TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE SKIN, INFECTIONS OF THE UROGENITAL TRACT, LOCALISED INFECTIONS IN SOFT TISSUE]

Status de autorização:

Registered

Data de autorização:

2023-07-01

Folheto informativo - Bula

KEFVET 250 MG TABLETS for Dogs and Cats
91578/132701
Product Name:
APVMA Approval No:
Label Name:
KEFVET 250 MG TABLETS for Dogs and Cats
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Each tablet contains 250 mg CEPHALEXIN
Claims:
For use by or under direction of a registered veterinarian.
For treatment of susceptible infections of the respiratory tract,
urogenital tract, the skin and
localised infections in soft tissue of dogs and cats, and of the
gastrointestinal tract in dogs.
When susceptible organisms are present KEFVET may be effective in the
treatment of
infections of the respiratory tract, urogenital tract, the skin and
localised infections in soft
tissue. In dogs, it may also be effective in the treatment of
infections of the gastrointestinal
tract.
Resistance may develop to any antimicrobial.
Net Contents:
10 [100 / 300] tablets
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated in animals that are hypersensitive to
cephalosporins and
penicillins.
Precautions:
Use with caution in cases of known renal insufficiency as accumulation
may occur in the
kidneys when renal function is impaired. Dose should be reduced. RLP APPROVED
Side Effects:
Some dogs may exhibit nausea and vomiting.
Dosage and
Administration:
The recommended oral dose rate is 10 to 15 mg/kg bodyweight twice
daily for 5 days.
In severe or acute conditions the dose may be safely doubled, or given
at more frequent
intervals.
Treatment for five days is recommended but this may be extended or
shortened at the
discretion of the veterinary surgeon.
Discard split tablets within 24 hours.
The following is intended as a guide:
KEFVET 50 mg Tablets
Up to 5 kg bodyweight 1 tablet twice daily
6 to 9 kg bodyweight 2 tablets twice daily
10 to 15 kg bodyweight 3 tablets twice daily
KEFVET 250 mg Tablets
10 to 25 kg bodyweight 1 tablet twice daily
26 to 50 kg bodyweight 2 tablets twice daily
51 kg and over bodyweight 3 tablets twice daily
KEFVET tab